Glenmark Pharmaceuticals Inc., USA recalls Abiraterone Acetate Tablets USP 500 mg
- Recalling company
- Glenmark Pharmaceuticals Inc., USA
- Product
- Abiraterone Acetate Tablets USP 500 mg, 60-count bottles, Rx only, Distributed by: Glenmark Pharmaceuticals USA, Elmwood Park, NJ 07407, NDC 68462-882-60
- Reason
- Labeling: Not Elsewhere Classified
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Oct 9, 2026
- Reported
- Nov 4, 2026
- Distribution
- Nationwide within the United States
- Status
- Ongoing
- Quantity
- 1296 bottles
- Lot / codes
- Lot #: 13250135, Exp. Date 11/2027
- Company location
- Elmwood Park, NJ
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0074-2027
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0074-2027 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.